China Alert

    View Author July 2009

    The US Food and Drug Administration (FDA) recently added two colleagues, Helen Xue and Mandy Fu, to its China Office. In November 2008 the FDA officially opened its China Office with locations in Beijing, Shanghai and Guangzhou to build stronger cooperative relationships with counterpart agencies in China and to take a proactive stance against unsafe food and drug products that are shipped to the United States. The arrival of new staff will help the FDA’s China Office better fulfill its functions. 

    Helen Xue

    • Position – Ms. Xue joins the FDA’s Shanghai Office as a medical research scientist.
    • Work Experience  – Ms. Xue comes directly from the US Consulate General Shanghai’s Environment, Science, Technology and Health Section, where she served for the last three years as the consulate’s health and environment specialist. Her responsibilities included building the consulate’s contacts with local government officials and industry and academia leaders, reporting on key developments and advising on US-China cooperation in the areas of public health and environmental protection. She also helped host numerous visits from US government officials including then-FDA Commissioner Dr. Andrew von Eschenbach’s visits to Shanghai in October 2007 and 2008 and then-US Department of Health & Human Services Secretary Michael Leavitt’s two visits to Shanghai in 2008. During most of her 14-year career, she has been working in fields closely related to pharmaceuticals and public health.
    • Educational Background – Ms. Xue received her master’s degree in public administration from Shanghai Jiao Tong University and her bachelor’s degree in pharmacy from Fudan University. She has received training in France and the United States related to quality testing, validation and good manufacturing practice (GMP) audits.

    Mandy Fu

    • Position – Ms. Fu joins the FDA’s Beijing Office as an administrative assistant and will hold responsibilities related to various operational components.
    • Work Experience – Ms. Fu comes directly from the Natural Products Association (NPA), the oldest and largest nongovernmental, nonprofit trade association in the United States focused on the dietary supplements industry. The responsibilities she held in her position with the NPA and her experience with related agencies in China’s government will contribute to the development of the FDA’s Beijing Office.
    • Educational Background – Ms. Fu holds a master’s degree in business English from Beijing International Studies University, as well as a bachelor’s degree in English language and literature from Shandong Normal University.

    Squire Sanders has extensive knowledge of food and drug product safety issues in China, having handled the class action lawsuits related to a highly publicized global pet food recall involving a China-based company that supplied tainted wheat gluten that ended up in pet food. For more information on navigating food and drug regulations in China, contact a member of the Squire Sanders team in any of the firm’s three offices in the country.